SCHEMBL2010859

SCHEMBL2010859

CN(C(=O)c1ccc2ocnc2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.66
HCRTR2 O43614 2/20 0.66
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CTNNB1 P35222 3/20 0.39
WNT3A P56704 3/20 0.39
HRH3 Q9Y5N1 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
PADI4 Q9UM07 3/20 0.35
TP53 P04637 1/20 0.35
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014534 0.94 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2013242 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2015950 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2010621 0.86 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9AHDAC6
SCHEMBL2014719 0.86 HCRTR1 (0.60) HCRTR1HCRTR2CTNNB1WNT3A
SCHEMBL2015002 0.86 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2015169 0.85 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9ACTNNB1
SCHEMBL2013098 0.84 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2011116 0.84 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2011513 0.84 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed